The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Cancer

• Publication date

  2006-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/cncr.22293PMID 17063503
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Stable expression of constitutively-activated STAT3 in benign prostatic epithelial cells changes their phenotype to that resembling malignant cells

  2005cited by this paper
• Molecular and prognostic distinction between serous ovarian carcinomas of varying grade and malignant potential

  2005cited by this paper
• The role of IL-6 and STAT3 in inflammation and cancer.

  2005cited by this paper
• Persistent STAT3 activation in colon cancer is associated with enhanced cell proliferation and tumor growth.

  2005cited by this paper
• Grading Ovarian Serous Carcinoma Using a Two-Tier System

  2004cited by this paper
• A Genetically Defined Model for Human Ovarian Cancer

  2004cited by this paper
• Activated Signal Transducer and Activator of Transcription (STAT) 3

  2004cited by this paper
• STAT proteins: From normal control of cellular events to tumorigenesis

  2003cited by this paper
• Discrete roles of cytokines, TNF-alpha, IL-1, IL-6 in tumor promotion and cell transformation.

  2002cited by this paper
• Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells.

  2002cited by this paper
• Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.

  2002cited by this paper
• Stat proteins and oncogenesis.

  2002cited by this paper
• Re: Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells.

  2002cited by this paper
• Discrete roles of cytokines, TNF-α, IL-1, IL-6 in tumor promotion and cell transformation

  2002cited by this paper
• Overexpression of HER-2 in ovarian carcinomas.

  2001cited by this paper
• Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells

  2001cited by this paper
• STATs in oncogenesis

  2000cited by this paper
• The role of STATs in transcriptional control and their impact on cellular function

  2000cited by this paper
• Epidermal growth factor receptor expression has no independent prognostic significance in advanced ovarian cancer.

  1999cited by this paper
• Stat3 as an oncogene.

  1999cited by this paper
• Mib-1 evaluated proliferative activity in ovarian cancer with respect to prognostic significance.

  1997cited by this paper
• Prospective on ovarian cancer: Why prevent?

  1995cited by this paper
• Immunohistochemical expression of EGF-R in malignant surface epithelial ovarian neoplasms (SEON).

  1994cited by this paper
• The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma.

  1994cited by this paper
• Epithelial ovarian carcinoma: principles of primary surgery.

  1994cited by this paper
• Secretion of bioactive interleukin-1, interleukin-6, and colony-stimulating factors by human ovarian surface epithelium.

  1993cited by this paper
• Simian virus 40-transformed human ovarian surface epithelial cells escape normal growth controls but retain morphogenetic responses to extracellular matrix.

  1992cited by this paper
• Revised FIGO staging for gynaecological cancer

  1989cited by this paper
• Human ovarian surface epithelium in primary culture

  1984cited by this paper
• The pathological assessment of ovarian neoplasms. I: Introduction to the common 'epithelial' tumours and analysis of benign 'epithelial' tumours.

  1979cited by this paper
• The pathological assessment of ovarian neoplasms. II: The proliferating 'epithelial' tumours.

  1979cited by this paper
• The pathological assessment of ovarian neoplasms. III: The malignant "epithelial" tumours.

  1979cited by this paper
• World Health Organization classification and nomenclature of ovarian cancer.

  1975cited by this paper

• Cryptolepine, a plant-derived alkaloid, differentially regulates signal transduction pathways in human embryonic kidney (HEK293) cells

  2023cites this paper
• Predicting Prognosis and Platinum Resistance in Ovarian Cancer: Role of Immunohistochemistry Biomarkers

  2023cites this paper
• Potential drug repurposing of ruxolitinib to inhibit the JAK/STAT pathway for the treatment of patients with epithelial ovarian cancer

  2023cites this paper
• Functional roles of long noncoding RNA MALAT1 in gynecologic cancers

  2022cites this paper
• Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer

  2022cites this paper
• Comparing the Secretomes of Chemorefractory and Chemoresistant Ovarian Cancer Cell Populations

  2022influential citation
• Effect of Soybean Isoflavones on Proliferation and Related Gene Expression of Sow Mammary Gland Cells In Vitro

  2022cites this paper
• Current and Futuristic Roadmap of Ovarian Cancer Management: An Overview.

  2021cites this paper
• IFN-γ inhibits ovarian cancer progression via SOCS1/JAK/STAT signaling pathway

  2021cites this paper
• Prognostic Value of TNFR2 and STAT3 among High-Grade Serous Ovarian Cancer Survivors According to Platinum Sensitivity

  2021cites this paper
• The impact of STAT3 and phospho-STAT3 expression on the prognosis and clinicopathology of ovarian cancer: a systematic review and meta-analysis

  2021cites this paper
• NR1D1 suppressed the growth of ovarian cancer by abrogating the JAK/STAT3 signaling pathway

  2021cites this paper
• Cryptolepine consolidates its anticancer potential by increasing the anti-cancer pathway genes and decreasing that of pro-cancer pathway genes

  2020cites this paper
• Leukotriene B 4 Receptor-2 Promotes Invasiveness and Metastasis of Ovarian Cancer Cells through Signal Transducer and Activator of Transcription 3 (STAT3)-dependent Up-regulation of Matrix Metalloproteinase 2

  2020cites this paper
• TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells

  2020cites this paper
• A novel small molecule LLL12B inhibits STAT3 signaling and sensitizes ovarian cancer cell to paclitaxel and cisplatin

  2020cites this paper
• MiR-375 inhibits the stemness of breast cancer cells by blocking the JAK2/STAT3 signaling.

  2020cites this paper
• Ovarian Cancer, Cancer Stem Cells and Current Treatment Strategies: A Potential Role of Magmas in the Current Treatment Methods

  2020cites this paper
• Bifunctional Naphthoquinone Aromatic Amide-Oxime Derivatives Exert Combined Immunotherapeutic and Antitumor Effects through Simultaneous Targeting of Indoleamine-2,3-dioxygenase and Signal Transducer and Activator of Transcription 3.

  2020cites this paper
• RETRACTED ARTICLE: Involvement of NORAD/miR-608/STAT3 axis in carcinostasis effects of physcion 8-O-β-glucopyranoside on ovarian cancer cells

  2019cites this paper
• Pectasol‐C Modified Citrus Pectin targets Galectin‐3‐induced STAT3 activation and synergize paclitaxel cytotoxic effect on ovarian cancer spheroids

  2019cites this paper
• Increasing Antitumor Activity of JAK Inhibitor by Simultaneous Blocking Multiple Survival Signaling Pathways in Human Ovarian Cancer

  2019cites this paper
• Ovarian cancer stem cells: What progress have we made?

  2019cites this paper
• OTT_A_214689 6297..6307

  2019influential citation
• miRNA551b-3p Activates an Oncostatin Signaling Module for the Progression of Triple-Negative Breast Cancer.

  2019cites this paper
• Activation of STAT3 and STAT5 Signaling in Epithelial Ovarian Cancer Progression: Mechanism and Therapeutic Opportunity

  2019cites this paper
• Deregulated Gab2 phosphorylation mediates aberrant AKT and STAT3 signaling upon PIK3R1 loss in ovarian cancer

  2019cites this paper
• Wnt/β-catenin signalling in ovarian cancer: Insights into its hyperactivation and function in tumorigenesis

  2019cites this paper
• Targeted activation of Stat3 in combination with paclitaxel results in increased apoptosis in epithelial ovarian cancer cells and a reduced tumour burden

  2019cites this paper
• Therapeutic Inducers of Apoptosis in Ovarian Cancer

  2019cites this paper
• MicroRNA-503-5p Inhibits the CD97-Mediated JAK2/STAT3 Pathway in Metastatic or Paclitaxel-Resistant Ovarian Cancer Cells

  2019cites this paper
• Ovarian Cancer Biomarkers in Proximal Fluids

  2019cites this paper
• LncRNA-MALAT1 regulates proliferation and apoptosis of ovarian cancer cells by targeting miR-503-5p

  2019cites this paper
• Zeylenone inhibits proliferation and promotes apoptosis in ovarian carcinoma cells via Janus kinase 2 / signal transducers and activators of transcription 3 pathways

  2018cites this paper
• Clinicopathological Significance and Antitumor Effect of MPHOSPH1 in Testicular Germ Cell Tumor

  2018cites this paper
• Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?

  2018influential citation
• STAT3/PIAS3 Levels Serve as "Early Signature" Genes in the Development of High-Grade Serous Carcinoma from the Fallopian Tube.

  2018cites this paper
• Lycopene Protects Against Spontaneous Ovarian Cancer Formation in Laying Hens

  2018cites this paper
• Pterostilbene Suppresses Ovarian Cancer Growth via Induction of Apoptosis and Blockade of Cell Cycle Progression Involving Inhibition of the STAT3 Pathway

  2018cites this paper
• JAK2/STAT3 pathway as a therapeutic target in ovarian cancers.

  2018cites this paper
• Ruxolitinib synergistically enhances the anti-tumor activity of paclitaxel in human ovarian cancer

  2018cites this paper
• Physapubescin B inhibits tumorgenesis and circumvents taxol resistance of ovarian cancer cells through STAT3 signaling

  2017cites this paper
• Targeting STAT3 by HO3867 induces apoptosis in ovarian clear cell carcinoma

  2017cites this paper
• The prognostic values of signal transducers activators of transcription family in ovarian cancer

  2017cites this paper
• Relationship between HER2 and JAK/STAT-SOCS3 signaling pathway and clinicopathological features and prognosis of ovarian cancer

  2017cites this paper
• Duffy antigen receptor for chemokines (DARC) expressing in cancer cells inhibits tumor progression by suppressing CXCR2 signaling in human pancreatic ductal adenocarcinoma

  2017cites this paper
• Gr upSM Interleukin-6 as a Therapeutic Target on Human Cancer

  2017cites this paper
• The Potential Role of Platelets in the Progression of Ovarian Cancer

  2017cites this paper
• Sparse Multi-Dimensional Graphical Models: A Unified Bayesian Framework

  2017cites this paper
• Activation of STAT 3 and its impacts on Proteasome Inhibitor-Induced Apoptosis in Laryngeal Sqaumous Carcinoma

  2017cites this paper
• Prognostic role of STAT3 in solid tumors: a systematic review and meta-analysis

  2016cites this paper
• Cucurbitacin I elicits the formation of actin/phospho-myosin II co-aggregates by stimulation of the RhoA/ROCK pathway and inhibition of LIM-kinase.

  2016cites this paper
• Onionin A inhibits ovarian cancer progression by suppressing cancer cell proliferation and the protumour function of macrophages

  2016cites this paper
• A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome

  2016cites this paper
• Chronic diseases caused by chronic inflammation require chronic treatment: The anti-inflammatory lifestyle

  2016cites this paper
• Direct Upregulation of STAT3 by MicroRNA-551b-3p Deregulates Growth and Metastasis of Ovarian Cancer.

  2016cites this paper
• Functions of Peroxisome Proliferator-Activated Receptor Gamma (PPARγ) in Gynecologic Disorders

  2015cites this paper
• Overcoming Chemoresistance of Pediatric Ependymoma by Inhibition of STAT3 Signaling

  2015cites this paper
• STAT3 inhibition reduces toxicity of oncolytic VSV and provides a potentially synergistic combination therapy for hepatocellular carcinoma

  2015cites this paper
• Investigational therapies targeting signal transducer and activator of transcription 3 for the treatment of cancer

  2015cites this paper
• Avalle L, Regis G, Poli V. Universal and Specific Functions of STAT3in Solid Tumours

  2015cites this paper
• IL6-induced metastasis modulators p-STAT3, MMP-2 and MMP-9 are targets of 3,3′-diindolylmethane in ovarian cancer cells

  2015cites this paper
• Synergistic anti-tumor effect of combined inhibition of EGFR and JAK/STAT3 pathways in human ovarian cancer

  2015cites this paper
• Inhibitor of signal transducer and activator of transcription 3 (STAT3) suppresses ovarian cancer growth, migration and invasion and enhances the effect of cisplatin in vitro.

  2015cites this paper
• Stat3 promotes invasion of esophageal squamous cell carcinoma through up-regulation of MMP2

  2015cites this paper
• Anti-Warburg effect of rosmarinic acid via miR-155 in gastric cancer cells

  2015cites this paper
• Structural perspective of ARHI mediated inhibition of STAT3 signaling: an insight into the inactive to active transition of ARHI and its interaction with STAT3 and importinβ.

  2015cites this paper
• Targeting JAK 1 / STAT 3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancer

  2014cites this paper
• Overcoming chemo-resistance of pediatric ependymoma by inhibition of STAT3 signaling

  2014cites this paper
• IL-6 Family and Cancer

  2014cites this paper
• Constitutive IDO expression in human cancer is sustained by an autocrine signaling loop involving IL-6, STAT3 and the AHR

  2014cites this paper
• Targeting JAK1/STAT3 Signaling Suppresses Tumor Progression and Metastasis in a Peritoneal Model of Human Ovarian Cancer

  2014cites this paper
• Suppression of STAT3 by chemically modified siRNAs increases the chemotherapeutic sensitivity of parental and cisplatin-resistant non-small cell lung cancer cells.

  2014cites this paper
• Suppression of STAT 3 by chemically modified siRNAs increases the chemotherapeutic sensitivity of parental and cisplatin-resistant non-small cell lung cancer cells

  2014cites this paper
• MicroRNA-302b Suppresses Human Epithelial Ovarian Cancer Cell Growth by Targeting RUNX1

  2014cites this paper
• Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden

  2014cites this paper
• IL-6 and related cytokines as the critical lynchpins between inflammation and cancer.

  2014cites this paper
• Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor

  2014cites this paper
• Function and regulation of MTA1 and MTA3 in malignancies of the female reproductive system

  2014cites this paper
• STAT3 and epithelial–mesenchymal transitions in carcinomas

  2014cites this paper
• Efficient inhibition of intraperitoneal ovarian cancer growth in nude mice by liposomal delivery of short hairpin RNA against STAT3

  2013cites this paper
• Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP.

  2013cites this paper
• Early responses of the STAT3 pathway to platinum drugs are associated with cisplatin resistance in epithelial ovarian cancer

  2013cites this paper
• Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research

  2013cites this paper
• Phosphorylation of signal transducer and activator of transcription 3 in soft tissue leiomyosarcoma is associated with a better prognosis

  2013cites this paper
• Silencing of the STAT3 signaling pathway reverses the inherent and induced chemoresistance of human ovarian cancer cells.

  2013cites this paper
• Minocycline Suppresses Interleukine-6, Its Receptor System and Signaling Pathways and Impairs Migration, Invasion and Adhesion Capacity of Ovarian Cancer Cells: In Vitro and In Vivo Studies

  2013cites this paper
• Mapping the Landscape of Acquired Vulnerabilities in Ovarian Cancer

  2013cites this paper
• Transcription factor STAT3 as a prognostic marker and therapeutic target in cancer.

  2013cites this paper
• The Role of Ect2 Nuclear RhoGEF Activity in Ovarian Cancer Cell Transformation.

  2013cites this paper
• Interleukin-6 signaling pathway in targeted therapy for cancer.

  2012cites this paper
• A Potent Oncolytic Adenovirus Selectively Blocks the STAT3 Signaling Pathway and Potentiates Cisplatin Antitumor Activity in Ovarian Cancer

  2012cites this paper
• Leukotriene B4 Receptor-2 Promotes Invasiveness and Metastasis of Ovarian Cancer Cells through Signal Transducer and Activator of Transcription 3 (STAT3)-dependent Up-regulation of Matrix Metalloproteinase 2*

  2012cites this paper
• Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3)

  2012influential citation
• Universal and Specific Functions of STAT3 in Solid Tumours

  2012cites this paper
• Preliminary evaluation of safety of conditionally replication adenovirus M4

  2012cites this paper
• Epithelial Ovarian Cancer – Adjuvant Measures with Potential for Slowing Its Spread and Boosting or Restoring its Chemosensitivity

  2012cites this paper
• Preliminary evaluation of safety of conditionally replication adenovirus M4

  2012cites this paper
• DIMming ovarian cancer growth.

  2012cites this paper
• Inflammation and ovarian cancer.

  2012cites this paper